Iron (III) hydroxide polymaltose complex is a water-soluble, macro molecular complex of polynuclear iron (III) hydroxide and partially hydrolyzed dextrin (polymaltose). It is rapidly absorbed with a high rate of iron utilization and produces an effective increase in haemoglobin.
Iron (III) hydroxide polymaltose complex is a water-soluble, macro molecular complex of polynuclear iron (III) hydroxide and partially hydrolyzed dextrin (polymaltose). It is rapidly absorbed with a high rate of iron utilization and produces an effective increase in haemoglobin.
Ipec Syrup: Each 5 ml contains iron hydroxide polymaltose complex INN 200 mg equivalent to 50 mg of elemental iron.
Prevention and treatment of all kinds of iron deficiency anemia.
Adult: 10 ml 1-2 times daily during or after meal.
Children under 12 years: 5 ml 1-2 times daily during or after meal. Infant: Start with 2.5 ml daily and increase to 5 ml daily.
Disturbances in iron utilization, thalassemia. Hypersensitivity or intolerance to iron and overloading of iron in the body. Anemia not caused by iron deficiency. Hypersensitivity to any ingredient of the formulation.
As with all iron preparations, a dark coloration of the stool may occur which is without clinical significance.
Ipec Syrup is well tolerated.
No interactions have been found between Ipec and food or between Ipec and other drugs due to its non-ionic nature.
Use in Pregnancy: Reproduction studies in animals did not show any fetal risk. Controlled studies in pregnant women after the first trimester have not shown any undesirable effects on mother and neonates. There is no evidence of a risk during the first trimester and the possibility of a negative influence to the fetus is unlikely to occur.
Use in Lactation: Mother's milk contains iron bound to lactoferrin. It is not known how much iron from the complex is passed into mother's milk. The administration of Ipec is unlikely to cause undesirable effects to the nursed child.
Ipec Syrup: Each bottle contains 100 ml syrup.
FR
DE
